Navigation Links
Novel cancer vaccine holds promise against ovarian cancer, mesothelioma
Date:3/5/2014

ovarian cancer and pancreatic cancer to a protein from the tuberculosis bacteria that stimulates the activity of dendritic and other immune cells. In this system, the dendritic cells are activated and targeted against tumor cells while remaining inside the patient's body.

In the experiments described in the paper, the MGH team confirmed that their mesothelin-targeting fusion protein binds to mesothelin on either ovarian cancer or mesothelioma cells, activates dendritic cells, and enhances the cells' processing and presentation of several different tumor antigens, inducing a number of T-cell-based immune responses. In mouse models of both tumors, treatment with the fusion protein significantly slowed tumor growth and extended survival, probably through the activity of cytotoxic CD8 T cells.

"Many patients with advanced cancers don't have enough functioning immune cells to be harvested to make a vaccine, but our protein can be made in unlimited amounts to work with the immune cells patients have remaining," explains study co-author Jeffrey Gelfand, MD, senior scientist at the Vaccine and Immunotherapy Center. "We have created a potentially much less expensive approach to making a therapeutic cancer vaccine that, while targeting a single tumor antigen, generates an immune response against multiple antigens. Now if we can combine this with newly-described ways to remove the immune system's "brakes" regulatory functions that normally suppress persistent T-cell activity the combination could dramatically enhance cancer immunotherapy."

Poznansky adds that the tumors that might be treated with the mesothelin-targeting vaccine ovarian cancer, pancreatic cancer and mesothelioma all have poor survival rates. "Immunotherapy is generally nontoxic, so this vaccine has the potential of safely extending survival and reducing the effects of these tumors, possibly even cutting the risk of recurrence. We believe that this approach could ultimately be
'/>"/>

Contact: Katie Marquedant
kmarquedant@partners.org
617-726-0337
Massachusetts General Hospital
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. A novel treatment may reduce myocardial infarction size
2. A new target for cancer and diabetes: A novel role for the adaptor protein p66shc in regulating glucose metabolism
3. Novel compound keeps Parkinsons symptoms at bay in mice
4. New company to develop novel gene therapies
5. Novel technique increases detection rate in screening mammography
6. Researchers find novel approach for controlling deadly C. difficile infections
7. Novel genes determine division of labor in insect societies
8. Novel biomarker approach suggests new avenues to improve schizophrenia disease management
9. Development of a novel dual JAK/Src kinase inhibitor
10. Jesus Was Not Born On December 25th - Controversial New Novel Tells Compelling Story About His Birth, Life and Death
11. Fatigue, a common side effect of breast cancer treatment, evaluated in novel patient study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Novel cancer vaccine holds promise against ovarian cancer, mesothelioma
(Date:7/31/2015)... ... , ... According to WFLA on July 16th, Sarasota has seen ... overdoses. Thricefold deaths have held steady over the last “couple of months” according to ... which was spurred by the crackdown of prescription painkillers. Many users who were addicted ...
(Date:7/31/2015)... Birmingham, Lake Orion, Clarkston, Metamora, Michigan (PRWEB) , ... ... ... of Midwives delivered the 100th baby at Beaumont Hospital's Karmanos Center for ... home-like environment for expectant mothers looking for a safe natural childbirth experience. With ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... Pediatric Emergency Medicine Practice, and Hospital Medicine Practice, is pleased to announce that ... in a mobile application format available on iPhones, iPads, and Android smartphones and ...
(Date:7/31/2015)... , ... July 31, 2015 , ... ... are 100% organic, natural, therapeutic-grade oils from ingredients sourced all over the world, ... that “With considerable effort, we have developed the highest-quality oils in the industry, ...
(Date:7/31/2015)... Baltimore, MD (PRWEB) , ... July 31, 2015 ... ... Lure Docs of All Types " from NBC talked about a woman’s unfortunate ... dermatology. He performed sclerotherapy on her face, which resulted in blistering, swelling, bruising, ...
Breaking Medicine News(10 mins):Health News:Sarasota Sufferers Increased Heroin Overdoses and Deaths 2Health News:Sarasota Sufferers Increased Heroin Overdoses and Deaths 3Health News:EB Medicine Launches Mobile Application for Pediatric Emergency Medicine 2Health News:EB Medicine Launches Mobile Application for Pediatric Emergency Medicine 3Health News:Living Pure Essential Oils takes Therepeutic Essential Oil Market by Storm 2Health News:Dermatologists Discuss Rise in Unqualified Practitioners of Cosmetic Dermatology 2Health News:Dermatologists Discuss Rise in Unqualified Practitioners of Cosmetic Dermatology 3
... , , , ... ATSI ), manufacturer and marketer of state-of-the-art cardiac surgery products ... 4, 2009. , , (Logo: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO ) , ... the quarter was $19.8 million, or 17.0% higher than the second quarter ...
... , , Results , , ... Corporation (Nasdaq: DRRX ) announced today financial results for the ... the three months ended June 30, 2009, compared to $6.3 million for ... ended June 30, 2009 was $7.5 million, compared to a net loss ...
... , , BIRMINGHAM, Ala., Aug. 3 ... reports Operating Income of $50.4 million, or $1.52 per diluted share for ... million, or $1.62 per diluted share. For the six months ended June ... and Net Income was $82.2 million, or $2.46 per diluted share. , ...
... activities, such as painting, study finds , MONDAY, Aug. ... time in front of the television, the computer and video ... a new study suggests. , American and Spanish researchers examined ... boys and girls, 3 to 8 years old. For seven ...
... An international ... may lead to new areas for drug development in melanoma - a cancer that is ... ... identified a new method for selectively killing metastatic melanoma cells, which may lead to new ...
... , NATICK, Mass., Aug. 3 Boston ... participate in the BMO Capital Markets 9(th) Annual Focus on ... Ray Elliott, President and Chief Executive Officer, will make a ... a.m. E.T. Following the presentation, Sam Leno, Executive Vice ...
Cached Medicine News:Health News:ATS Medical Announces Second Quarter 2009 Results 2Health News:ATS Medical Announces Second Quarter 2009 Results 3Health News:ATS Medical Announces Second Quarter 2009 Results 4Health News:ATS Medical Announces Second Quarter 2009 Results 5Health News:ATS Medical Announces Second Quarter 2009 Results 6Health News:ATS Medical Announces Second Quarter 2009 Results 7Health News:ATS Medical Announces Second Quarter 2009 Results 8Health News:ATS Medical Announces Second Quarter 2009 Results 9Health News:ATS Medical Announces Second Quarter 2009 Results 10Health News:ATS Medical Announces Second Quarter 2009 Results 11Health News:DURECT Corporation Announces Second Quarter 2009 Financial 2Health News:DURECT Corporation Announces Second Quarter 2009 Financial 3Health News:DURECT Corporation Announces Second Quarter 2009 Financial 4Health News:DURECT Corporation Announces Second Quarter 2009 Financial 5Health News:DURECT Corporation Announces Second Quarter 2009 Financial 6Health News:DURECT Corporation Announces Second Quarter 2009 Financial 7Health News:DURECT Corporation Announces Second Quarter 2009 Financial 8Health News:DURECT Corporation Announces Second Quarter 2009 Financial 9Health News:ProAssurance Reports Second Quarter 2009 Results 2Health News:ProAssurance Reports Second Quarter 2009 Results 3Health News:ProAssurance Reports Second Quarter 2009 Results 4Health News:ProAssurance Reports Second Quarter 2009 Results 5Health News:ProAssurance Reports Second Quarter 2009 Results 6Health News:ProAssurance Reports Second Quarter 2009 Results 7Health News:ProAssurance Reports Second Quarter 2009 Results 8Health News:ProAssurance Reports Second Quarter 2009 Results 9Health News:ProAssurance Reports Second Quarter 2009 Results 10Health News:ProAssurance Reports Second Quarter 2009 Results 11Health News:ProAssurance Reports Second Quarter 2009 Results 12Health News:ProAssurance Reports Second Quarter 2009 Results 13Health News:Young Kids' Screen Time May Raise Blood Pressure 2Health News:Researchers Identify New Method to Selectively Kill Metastatic Melanoma Cells 2Health News:Researchers Identify New Method to Selectively Kill Metastatic Melanoma Cells 3
(Date:7/31/2015)... -- The Physician-Patient Alliance for Health & Safety ... "Surviving Your Hospital Stay: Physician-Patient Alliance for Health ... A sentence was omitted from the release. ... is a member of the National Coalition to Promote ... the National Coalition to Promote Continuous Monitoring of Patients ...
(Date:7/31/2015)... July 31, 2015 According to a ... (Moist Heat, Dry Heat, Ethylene Oxide, Filtration, E-beam, Gamma), Services ... (Hospitals, Pharmaceuticals) - Global Forecast to 2020", published by MarketsandMarkets, ... 6.1 Billion by 2020, at a CAGR of 7.6%.from 2015 ... market data T ables and 37 ...
(Date:7/31/2015)... , July 31, 2015 Quietly, ... of experience, the domestic pharmaceutical industry is strong, with ... products to high international standards. One place ... is in sub-Saharan Africa: Morocco has quietly become the ... South Africa . Indeed, Moroccan pharma companies ...
Breaking Medicine Technology:Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 2Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 3Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 4PharmaBoardroom Releases New Morocco Pharmaceuticals Report 2PharmaBoardroom Releases New Morocco Pharmaceuticals Report 3
... Jan. 21, 2011 Matrixx Initiatives, Inc. (Nasdaq: ... healthcare company that develops and markets Zicam® products, today ... by the Agreement and Plan of Merger, dated as ... Holdings, Inc. ("Wonder") and Wonder Holdings Acquisition Corp. (the ...
... Ariz., Jan. 20, 2011 Matrixx Initiatives, Inc. (Nasdaq: ... markets Zicam® products, today announced financial results for its fiscal ... For the third quarter ended December 31, 2010, ... below the $28.5 million in net sales for the comparable ...
Cached Medicine Technology:Matrixx Initiatives, Inc. Summarizes Ongoing 'Go-Shop' Process and Board Reaffirms Recommendation 2Matrixx Initiatives, Inc. Summarizes Ongoing 'Go-Shop' Process and Board Reaffirms Recommendation 3Matrixx Initiatives, Inc. Summarizes Ongoing 'Go-Shop' Process and Board Reaffirms Recommendation 4Matrixx Initiatives, Inc. Summarizes Ongoing 'Go-Shop' Process and Board Reaffirms Recommendation 5Matrixx Initiatives, Inc. Reports Fiscal 2011 Third Quarter Net Sales of $20.3 Million and Net Loss of $11.3 Million, or $(1.21) Per Share 2Matrixx Initiatives, Inc. Reports Fiscal 2011 Third Quarter Net Sales of $20.3 Million and Net Loss of $11.3 Million, or $(1.21) Per Share 3Matrixx Initiatives, Inc. Reports Fiscal 2011 Third Quarter Net Sales of $20.3 Million and Net Loss of $11.3 Million, or $(1.21) Per Share 4Matrixx Initiatives, Inc. Reports Fiscal 2011 Third Quarter Net Sales of $20.3 Million and Net Loss of $11.3 Million, or $(1.21) Per Share 5
The ACP 215 is the automated closed system cell processor with integrated process control....
... Blood collection centers throughout the world are ... improve the safety of the blood supply ... a constantly shrinking donor base. Clearly, these ... self-sufficient, to better manage their existing donor ...
The Plasma Extractor is used to express blood components from collection containers. The spring-loaded front panel exerts pressure on the collection container causing the fluid to transfer until cont...
The Eppendorf Maxipettor is a continuously adjustable pipette for precise pipetting of volumes up to 10 ml (in 10 l increments). Even liquids with a high vapor pressure or viscosity can be pipetted w...
Medicine Products: